Broyhill Asset Management’s Pfizer PFE Stock Holding History

Broyhill Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Hold	8,500	–	–	0.18%	76
2026 Q1	$239K	Hold	8,500	–	–	0.22%	71
2025 Q4	$212K	Hold	8,500	–	–	0.19%	71
2025 Q3	$217K	Hold	8,500	–	–	0.19%	75
2025 Q2	$206K	Hold	8,500	–	–	0.19%	71
2025 Q1	$215K	Sell	8,500 -200	-2%	-$5.23K	0.18%	73
2024 Q4	$231K	Buy	+8,700	New	+$236K	0.2%	68

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Broyhill Asset Management's PFE Position: Q2 2026 in Review

Broyhill Asset Management held its Pfizer (PFE) position steady in Q2 2026 at 8,500 shares worth $205K. The position accounts for 0.18% of the portfolio, ranked #76.

Broyhill Asset Management first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $239K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Broyhill Asset Management held 8,500 shares of Pfizer worth $205K as of Q2 2026.
Broyhill Asset Management left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.18% of Broyhill Asset Management's portfolio in Q2 2026, its #76 holding.
Broyhill Asset Management first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Broyhill Asset Management's Pfizer position peaked at $239K in Q1 2026.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Broyhill Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.